 Delayed-Action Preparations
"Delayed-Action Preparations" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Dosage forms of a drug that act over a period of time by controlled-release processes or technology.
| Descriptor ID |
D003692
|
| MeSH Number(s) |
D26.255.210 E02.319.300.253
|
| Concept/Terms |
Controlled-Release Preparations- Controlled-Release Preparations
- Controlled Release Preparations
- Controlled-Release Preparation
- Controlled-Release Formulations
- Controlled Release Formulations
- Controlled-Release Formulation
Sustained-Release Preparations- Sustained-Release Preparations
- Sustained-Release Preparation
- Extended Release Preparations
- Extended Release Preparation
- Slow Release Formulation
- Sustained Release Formulations
- Sustained Release Formulation
- Extended Release Formulations
- Extended Release Formulation
|
Below are MeSH descriptors whose meaning is more general than "Delayed-Action Preparations".
Below are MeSH descriptors whose meaning is more specific than "Delayed-Action Preparations".
This graph shows the total number of publications written about "Delayed-Action Preparations" by people in this website by year, and whether "Delayed-Action Preparations" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 3 | 3 | | 1997 | 0 | 1 | 1 | | 1999 | 1 | 2 | 3 | | 2000 | 0 | 2 | 2 | | 2001 | 0 | 1 | 1 | | 2002 | 1 | 4 | 5 | | 2003 | 1 | 2 | 3 | | 2005 | 1 | 4 | 5 | | 2006 | 2 | 2 | 4 | | 2007 | 0 | 7 | 7 | | 2008 | 0 | 4 | 4 | | 2010 | 0 | 3 | 3 | | 2011 | 2 | 5 | 7 | | 2012 | 2 | 4 | 6 | | 2013 | 2 | 8 | 10 | | 2014 | 0 | 5 | 5 | | 2015 | 2 | 5 | 7 | | 2016 | 3 | 5 | 8 | | 2017 | 0 | 7 | 7 | | 2018 | 4 | 6 | 10 | | 2019 | 0 | 3 | 3 | | 2020 | 0 | 8 | 8 | | 2021 | 0 | 4 | 4 | | 2023 | 0 | 3 | 3 | | 2024 | 4 | 4 | 8 | | 2025 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Delayed-Action Preparations" by people in Profiles.
-
Li J, Patel SK, Sweeney Y, Patton D, Anderson P, Hillier SL, Rohan LC. Engineering vaginal film platform for mucoadhesion and sustained drug release for HIV-1 prevention. J Control Release. 2025 Mar 10; 379:696-707.
-
Y Bernstein E, Magane KM, Dukes KA, Palfai TP, Lee JH, Saitz R, Samet JH. Correlates of post-hospitalization naltrexone adherence for alcohol use disorder. Drug Alcohol Depend. 2024 Dec 01; 265:112470.
-
Coleman HJ, Yang Q, Robert A, Padgette H, Funke HH, Catalano CE, Randolph TW. Formulation of three tailed bacteriophages by spray-drying and atomic layer deposition for thermal stability and controlled release. J Pharm Sci. 2024 Nov; 113(11):3238-3245.
-
Adhikari B, Stager MA, Collins EG, Fischenich KM, Olusoji J, Ruble AF, Payne KA, Krebs MD. Sustained release of MAPK14-targeting siRNA from polyelectrolyte complex hydrogels mitigates MSC osteogenesis in vitro with potential application in growth plate injury. J Biomed Mater Res A. 2024 12; 112(12):2346-2357.
-
Rael CT, Das D, Porter J, Lopez-R?os J, Abascal E, Dolezal C, Vaughn MP, Giffenig P, Lopez JM, Stonbraker S, Sun C, Velasco RA, Bitterfeld L, Bockting WO, Bauermeister J. Provider Factors Likely to Impact Access and Uptake of Long-Acting Injectable Cabotegravir for Transgender Women in the United States: Results of a Qualitative Study. J Assoc Nurses AIDS Care. 2024 Sep-Oct 01; 35(5):437-449.
-
Bae EK, Chandran MM, Everitt MD, Benz E, Bock M. LCP-Tacrolimus Extended-Release (Envarsus XR) Use in Adolescent and Young Adult Solid Organ Transplant Recipients. Clin Transplant. 2024 Aug; 38(8):e15417.
-
Haser GC, Balter L, Gurley S, Thomas M, Murphy T, Sumitani J, Leue EP, Hollman A, Karneh M, Wray L, Washington M, Corbin-Johnson D, Condra A, Niles-Carnes L, Smith BL, Armstrong WS, Kalokhe AS, Colasanti JA, Collins LF. Early Implementation and Outcomes Among People with HIV Who Accessed Long-Acting Injectable Cabotegravir/Rilpivirine at Two Ryan White Clinics in the U.S. South. AIDS Res Hum Retroviruses. 2024 Dec; 40(12):690-700.
-
Strong TV, Miller JL, McCandless SE, Gevers E, Yanovski JA, Matesevac L, Bohonowych J, Ballal S, Yen K, Hirano P, Cowen NM, Bhatnagar A. Behavioral changes in patients with Prader-Willi syndrome receiving diazoxide choline extended-release tablets compared to the PATH for PWS natural history study. J Neurodev Disord. 2024 Apr 26; 16(1):22.
-
Christine PJ, Lodi S, Hsu HE, Bovell-Ammon B, Yan S, Bernson D, Novo P, Lee JD, Rotrosen J, Liebschutz J, Walley AY, Larochelle MR. Target trial emulation for comparative effectiveness research with observational data: Promise and challenges for studying medications for opioid use disorder. Addiction. 2024 07; 119(7):1313-1321.
-
Severtson SG, Haanschoten EE, Iwanicki J, Dart RC. Differences in severity of poison centers exposures involving XTAMPZA? ER versus other opioid analgesics. Pain Manag. 2023 Sep; 13(9):519-527.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|